Compare · head to head
Dr. Lal PathLabs vs Fleury
Fleury ranks higher overall — 360 rank 95 vs 62.
Fleury leads on Value (71 vs 22). Dr. Lal PathLabs leads on Safety (67 vs 57). The two are close on Quality, Growth and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | India | Brazil |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Providers & Services |
| Size | Medium | Large |
| ISIN | INE600L01024 | BRFLRYACNOR5 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 62 | 95 |
| Value | 22 | 71 |
| Quality | 73 | 74 |
| Growth | 54 | 58 |
| Safety | 67 | 57 |
| Sentiment | 47 | 46 |
| Quality details | ||
| Profitability | 92 | 68 |
| Cash Truth | 54 | 79 |
Dr. Lal PathLabs vs Metropolis HealthcareDr. Lal PathLabs vs Bangkok Chain HospitalDr. Lal PathLabs vs NetcareDr. Lal PathLabs vs Mahachai HospitalAdd a third stock →
Full analyses: Dr. Lal PathLabs · Fleury
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100